<DOC>
	<DOCNO>NCT02505139</DOCNO>
	<brief_summary>A circulating tumor cell ( CTC ) count establish prognostic factor malignancy metastatic breast cancer . However , value CTC diagnosis outcome prediction metastatic nasopharyngeal carcinoma ( mNPC ) patient unknown . Through observational prospective clinical trial , sensitivity , specificity , positive negative predictive value CTC diagnosis mNPC patient gain . Further , value CTC outcome prediction mNPC patient uncover .</brief_summary>
	<brief_title>The Value Diagnosis Outcome Prediction CTC Metastatic NPC Patients</brief_title>
	<detailed_description />
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>Histologically radiologically confirm nasopharyngeal nonkeratinizing carcinoma ( WHO II , III ) . NPC patient distant metastasis include synchronous distant metastasis diagnosis metachronous distant metastasis radical treatment . A Karnofsky performance status score 70 . The participant provide write informed consent . A history previous synchronous malignant tumor . Suffering severe mental illness synchronously . Suffering severe heart lung disease . Obvious abnormality liver renal function . Women pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>nasopharyngeal carcinoma</keyword>
	<keyword>distant metastasis</keyword>
	<keyword>circulate tumor cell</keyword>
	<keyword>outcome prediction</keyword>
</DOC>